Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

93734

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Transatlantic Trade and Investment Partnership
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their assessment of the implications for the National Health Service of a successful outcome to the ongoing Transatlantic Trade and Investment Partnership negotiations between the European Union and the United States.
tabling member printed	Lord Empey
uin	HL2158
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>The Transatlantic Trade and Investment Partnership (TTIP) will not affect the way the United Kingdom Government runs the National Health Service. It has been made clear by negotiators from both the United States and the European Union that it is up to the UK alone to decide how the NHS is run and any assertion that TTIP will undermine the Government’s control of the NHS is a red herring.</p><p> </p><p> </p><p> </p><p>The TTIP could offer great benefits to British business and for British jobs. Greater consistency in existing and new regulatory requirements would make it easier for companies - especially small and medium enterprises - to access markets and, for patients, potentially help to increase access to new medicines and medical devices.</p><p> </p> answering member printed Earl Howe question first answered 21/10/2014 11:09:44 answering member 2000 label Biography information for Earl Howe
tabling member	4216 label Biography information for Lord Empey

93738

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they will take to make the National Health Service more efficient and to reduce mistakes in practice.
tabling member printed	Lord Taylor of Warwick
uin	HL2162
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>National Health Service funding has risen in each year of this parliament and is £12.7 billion higher in cash terms in 2014-15 than in 2010-11. The NHS is on track to make up to £20 billion efficiency savings this parliament to reinvest into frontline care. We are confident that it will continue to make the efficiency improvements necessary to meet rising demand and protect the quality of the services delivered.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>In a recent report commissioned by the Department, Frontier Economics has estimated that poor care could be costing the NHS up to £2.5 billion every year. In order to focus attention on the harms contributing to these costs and the savings that could be reinvested, a poster and leaflet will go out to all NHS hospitals to display this vital information to their staff.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>We have introduced a wide range of measures, including the Sign Up to Safety Campaign, Patient Safety Collaboratives, a new tougher inspection regime for providers and a reformed National Patient Safety Alert System to reduce mistakes in practice. In order to promote a culture of openness and transparency, that will enable organisations to learn from their mistakes, there will be the duty of candour in the event of serious harm. We are also publishing information on hospital performance, including staffing levels, as part of the new MyNHS website.</p><p> </p> answering member printed Earl Howe question first answered 21/10/2014 11:10:41 answering member 2000 label Biography information for Earl Howe
tabling member	1796 label Biography information for Lord Taylor of Warwick

93837

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Plastic Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will bring forward legislative proposals to ensure that regulations regarding invasive cosmetic procedures provide the same level of protection as those concerning cosmetic surgery.
tabling member constituency	Mid Dorset and North Poole
tabling member printed	Annette Brooke
uin	210880
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>On 24 April 2013, the independent <em>Review of the Regulation of Cosmetic Interventions</em>, chaired by Sir Bruce Keogh, was published. A copy has already been placed in the Library.</p><p> </p><p>The <em>Government Response to the Review of the Regulation of Cosmetic Interventions </em>was published on 13 February. A copy of the response has already been placed in the Library. We fully accept the principles of the Keogh review and the overwhelming majority of the recommendations. The response looks to protect the public through clear standards, better training and robust qualifications, and explores how far supervision from regulated professionals might support self-regulation of the sector.</p><p> </p><p>Officials are working with key delivery partners such as the Royal College of Surgeons who have set up an inter-specialty committee to ensure standards for cosmetic surgery and they are working with the General Medical Council on a code of ethical conduct. Health Education England (HEE) is leading on a review of training and qualifications for providers of non-surgical cosmetic interventions and those required to be responsible prescribers. On 11 September, HEE published a phase 1 report <em>Review of qualifications required for delivery of non-surgical cosmetic </em>interventions. A copy of the report is attached. Work is also underway on a pilot breast implant registry to reassure women that if problems arise they can be contacted, kept informed and called in for treatment if necessary.</p><p> </p><p>As part of this programme of work to ensure proper training and oversight of both non-surgical and surgical cosmetic interventions, we are looking at the need for legislation to ensure public protection and will consider bringing forward proposals.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 21/10/2014 15:16:47 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name Non-surgical cosmetic interventions - Report on Phase 1 - final.pdf title Non-surgical cosmetic interventions Report
tabling member	1431 label Biography information for Annette Brooke

93839

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what National Institute for Health and Care Excellence-approved interventions are available through the NHS for the treatment of mental health conditions.
tabling member constituency	East Worthing and Shoreham
tabling member printed	Tim Loughton
uin	210896
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>The National Institute for Health and Care Excellence (NICE) has published clinical guidelines on a range of mental health topics, such as depression, anxiety and schizophrenia. Clinical guidelines provide guidance on the treatment of patients across the care pathway and each guideline recommends a number of treatments.<br> <br> Additionally, the following technologies for the treatment of mental health and behavioural conditions are recommended by NICE technology appraisal guidance:</p><p> </p><table><tbody><tr><td><p>Appraisal Number</p></td><td><p>Year</p></td><td><p>Technology</p></td><td><p>Condition</p></td><td><p>Categorisation</p></td></tr><tr><td><p>TA59</p></td><td><p>2003</p></td><td><p>Electroconvulsive therapy</p></td><td><p>Catatonia/ prolonged or severe manic episode</p></td><td><p>Optimised<sup>1</sup></p></td></tr><tr><td><p>TA098</p></td><td><p>2006</p></td><td><p>Atomoxetine</p></td><td><p>Attention deficit hyperactivity disorder (ADHD)</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA098</p></td><td><p>2006</p></td><td><p>Dexamfetamine</p></td><td><p>Attention deficit hyperactivity disorder (ADHD)</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA098</p></td><td><p>2006</p></td><td><p>Methylphenidate</p></td><td><p>Attention deficit hyperactivity disorder (ADHD)</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA213</p></td><td><p>2011</p></td><td><p>Aripiprazole</p></td><td><p>Schizophrenia in people aged 15-17 years</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA217</p></td><td><p>2011</p></td><td><p>Donepezil</p></td><td><p>Alzheimer's disease (mild to moderate)</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA217</p></td><td><p>2011</p></td><td><p>Galantamine</p></td><td><p>Alzheimer's disease (mild to moderate)</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA217</p></td><td><p>2011</p></td><td><p>Rivastigmine</p></td><td><p>Alzheimer's disease (mild to moderate)</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA217</p></td><td><p>2011</p></td><td><p>Memantine</p></td><td><p>Alzheimer's disease (moderate)</p></td><td><p>Optimised</p></td></tr><tr><td><p>TA217</p></td><td><p>2011</p></td><td><p>Memantine</p></td><td><p>Alzheimer's disease (severe)</p></td><td><p>Recommended</p></td></tr><tr><td><p>TA292</p></td><td><p>2013</p></td><td><p>Aripiprazole</p></td><td><p>Moderate to severe manic episodes in adolescents with bipolar disorder</p></td><td><p>Recommended</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Source</em>: National Institute for Health and Care Excellence</p><p> </p><p> </p><p> </p><p><sup>1 </sup>The drug or technology is recommended for a smaller subset of patients than originally stated by the marketing authorisation.</p><p> </p><p> </p><p> </p><p>Patients have the right to drugs and treatments that have been recommended by NICE technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate.</p><p> </p><p> </p><p> </p><p>Details of all NICE’s guidance on mental health and behavioural conditions can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/guidancemenu/conditions-and-diseases/mental-health-and-behavioural-conditions" target="_blank">www.nice.org.uk/guidancemenu/conditions-and-diseases/mental-health-and-behavioural-conditions</a></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/10/2014 15:12:00 answering member 4020 label Biography information for George Freeman
tabling member	114 label Biography information for Tim Loughton

100021

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Home Care Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will bring forward proposals to facilitate the portability of home-based care packages between local authorities in different countries in the UK.
tabling member constituency	Edinburgh East
tabling member printed	Sheila Gilmore
uin	905560
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>Adults with care and support needs should be able to move between countries within the United Kingdom knowing that their care will continue during the move.</p><p> </p><p> </p><p> </p><p>As the care and support systems in the four countries are different, we are developing principles with the Devolved Administrations to ensure continuity of care for people moving.</p><p> </p><p>These should be published in November.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 21/10/2014 15:45:44 answering member 1439 label Biography information for Norman Lamb
tabling member	3965 label Biography information for Sheila Gilmore

100024

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Community Health Services: Devon
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will increase funding from the Better Care Fund to improve the transition of community services in Devon.
tabling member constituency	North Devon
tabling member printed	Sir Nick Harvey
uin	905558
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>The Better Care Fund is a pooled budget of £3.8 billion to be spent on integrating Health and Social care. Local areas will decide how best to use their funding to transform the provision of services to their communities, both improving outcomes for people, and driving efficiencies.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 21/10/2014 15:44:45 answering member 1439 label Biography information for Norman Lamb
tabling member	231 label Biography information for Sir Nick Harvey

93560

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospitals: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in Warrington waited more than 18 weeks for treatment in each year from 2010.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	210668
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p><strong> </strong></p><p> </p><p>The data is not available in the format requested. The following table shows the number of patients who waited or were waiting over 18 weeks from referral to first treatment at Warrington and Halton NHS Foundation Trust in each month from January 2010 to August 2014.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Admitted (adjusted) pathways</p></td><td><p>Non-admitted pathways</p></td><td><p>Incomplete pathways</p></td></tr><tr><td><p>January 2010</p></td><td><p>101</p></td><td><p>57</p></td><td><p>1,178</p></td></tr><tr><td><p>February 2010</p></td><td><p>110</p></td><td><p>65</p></td><td><p>1,269</p></td></tr><tr><td><p>March 2010</p></td><td><p>138</p></td><td><p>57</p></td><td><p>1,314</p></td></tr><tr><td><p>April 2010</p></td><td><p>87</p></td><td><p>72</p></td><td><p>1,340</p></td></tr><tr><td><p>May 2010</p></td><td><p>108</p></td><td><p>54</p></td><td><p>1,316</p></td></tr><tr><td><p>June 2010</p></td><td><p>98</p></td><td><p>68</p></td><td><p>1,426</p></td></tr><tr><td><p>July 2010</p></td><td><p>112</p></td><td><p>62</p></td><td><p>1,481</p></td></tr><tr><td><p>August 2010</p></td><td><p>74</p></td><td><p>36</p></td><td><p>1,592</p></td></tr><tr><td><p>September 2010</p></td><td><p>99</p></td><td><p>36</p></td><td><p>1,552</p></td></tr><tr><td><p>October 2010</p></td><td><p>96</p></td><td><p>40</p></td><td><p>1,460</p></td></tr><tr><td><p>November 2010</p></td><td><p>94</p></td><td><p>48</p></td><td><p>1,530</p></td></tr><tr><td><p>December 2010</p></td><td><p>70</p></td><td><p>26</p></td><td><p>1,626</p></td></tr><tr><td><p>January 2011</p></td><td><p>84</p></td><td><p>42</p></td><td><p>1,583</p></td></tr><tr><td><p>February 2011</p></td><td><p>81</p></td><td><p>29</p></td><td><p>1,451</p></td></tr><tr><td><p>March 2011</p></td><td><p>106</p></td><td><p>58</p></td><td><p>1,156</p></td></tr><tr><td><p>April 2011</p></td><td><p>72</p></td><td><p>25</p></td><td><p>1,104</p></td></tr><tr><td><p>May 2011</p></td><td><p>81</p></td><td><p>38</p></td><td><p>1,105</p></td></tr><tr><td><p>June 2011</p></td><td><p>75</p></td><td><p>20</p></td><td><p>1,228</p></td></tr><tr><td><p>July 2011</p></td><td><p>82</p></td><td><p>38</p></td><td><p>1,801</p></td></tr><tr><td><p>August 2011</p></td><td><p>79</p></td><td><p>45</p></td><td><p>1,830</p></td></tr><tr><td><p>September 2011</p></td><td><p>96</p></td><td><p>36</p></td><td><p>1,366</p></td></tr><tr><td><p>October 2011</p></td><td><p>107</p></td><td><p>60</p></td><td><p>1,403</p></td></tr><tr><td><p>November 2011</p></td><td><p>154</p></td><td><p>71</p></td><td><p>1,453</p></td></tr><tr><td><p>December 2011</p></td><td><p>130</p></td><td><p>68</p></td><td><p>1,530</p></td></tr><tr><td><p>January 2012</p></td><td><p>127</p></td><td><p>129</p></td><td><p>1,474</p></td></tr><tr><td><p>February 2012</p></td><td><p>119</p></td><td><p>68</p></td><td><p>1,363</p></td></tr><tr><td><p>March 2012</p></td><td><p>138</p></td><td><p>90</p></td><td><p>924</p></td></tr><tr><td><p>April 2012</p></td><td><p>126</p></td><td><p>49</p></td><td><p>881</p></td></tr><tr><td><p>May 2012</p></td><td><p>125</p></td><td><p>45</p></td><td><p>885</p></td></tr><tr><td><p>June 2012</p></td><td><p>120</p></td><td><p>58</p></td><td><p>888</p></td></tr><tr><td><p>July 2012</p></td><td><p>143</p></td><td><p>85</p></td><td><p>834</p></td></tr><tr><td><p>August 2012</p></td><td><p>124</p></td><td><p>68</p></td><td><p>867</p></td></tr><tr><td><p>September 2012</p></td><td><p>159</p></td><td><p>75</p></td><td><p>821</p></td></tr><tr><td><p>October 2012</p></td><td><p>150</p></td><td><p>85</p></td><td><p>819</p></td></tr><tr><td><p>November 2012</p></td><td><p>156</p></td><td><p>46</p></td><td><p>880</p></td></tr><tr><td><p>December 2012</p></td><td><p>103</p></td><td><p>42</p></td><td><p>844</p></td></tr><tr><td><p>January 2013</p></td><td><p>131</p></td><td><p>68</p></td><td><p>870</p></td></tr><tr><td><p>February 2013</p></td><td><p>158</p></td><td><p>66</p></td><td><p>884</p></td></tr><tr><td><p>March 2013</p></td><td><p>156</p></td><td><p>54</p></td><td><p>872</p></td></tr><tr><td><p>April 2013</p></td><td><p>151</p></td><td><p>52</p></td><td><p>930</p></td></tr><tr><td><p>May 2013</p></td><td><p>153</p></td><td><p>60</p></td><td><p>975</p></td></tr><tr><td><p>June 2013</p></td><td><p>165</p></td><td><p>51</p></td><td><p>923</p></td></tr><tr><td><p>July 2013</p></td><td><p>174</p></td><td><p>75</p></td><td><p>870</p></td></tr><tr><td><p>August 2013</p></td><td><p>134</p></td><td><p>56</p></td><td><p>951</p></td></tr><tr><td><p>September 2013</p></td><td><p>165</p></td><td><p>71</p></td><td><p>831</p></td></tr><tr><td><p>October 2013</p></td><td><p>147</p></td><td><p>59</p></td><td><p>800</p></td></tr><tr><td><p>November 2013</p></td><td><p>158</p></td><td><p>62</p></td><td><p>772</p></td></tr><tr><td><p>December 2013</p></td><td><p>106</p></td><td><p>79</p></td><td><p>722</p></td></tr><tr><td><p>January 2014</p></td><td><p>141</p></td><td><p>85</p></td><td><p>704</p></td></tr><tr><td><p>February 2014</p></td><td><p>123</p></td><td><p>57</p></td><td><p>687</p></td></tr><tr><td><p>March 2014</p></td><td><p>120</p></td><td><p>65</p></td><td><p>655</p></td></tr><tr><td><p>April 2014</p></td><td><p>126</p></td><td><p>59</p></td><td><p>662</p></td></tr><tr><td><p>May 2014</p></td><td><p>117</p></td><td><p>72</p></td><td><p>675</p></td></tr><tr><td><p>June 2014</p></td><td><p>111</p></td><td><p>45</p></td><td><p>636</p></td></tr><tr><td><p>July 2014</p></td><td><p>177</p></td><td><p>79</p></td><td><p>656</p></td></tr><tr><td><p>August 2014</p></td><td><p>160</p></td><td><p>75</p></td><td><p>581</p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source: </em>NHS England</p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><ol start="1" type="1"><li>Admitted (adjusted) pathways means inpatients/day-cases during the month.</li><li>Non-admitted pathways means outpatient pathways, and pathways that end without treatment.</li><li>Incomplete pathways means the number of patients still waiting at the month end.</li><li>Data cannot be aggregated into years as incomplete pathways data provides a snapshot at each month end.</li></ol><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/10/2014 16:25:09 answering member 3918 label Biography information for Jane Ellison
tabling member	432 label Biography information for Helen Jones

93566

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the value is of the rebate payments made by industry under the Pharmaceutical Price Regulation Scheme to date; and what proportion of that rebate has been reinvested in (i) healthcare services and (ii) medicines expenditure.
tabling member constituency	Cambridge
tabling member printed	Dr Julian Huppert
uin	210640
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014 and £76 million in respect of the second quarter. The Department will publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first two quarters PPRS payments were published in June and September 2014 respectively and can be found on the Government’s website at:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p> </p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:15:30 answering member 4020 label Biography information for George Freeman
tabling member	3931 label Biography information for Dr Julian Huppert

93567

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ebola
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many quarantined hospital beds the UK has capacity to provide for Ebola treatment.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	210739
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The Secretary of State laid out what hospital facilities were available for the treatment of Ebola patients during his statement to the House on 13 October 2014, Official Report, columns 28 to 46.</p><p> </p><p> </p><p> </p><p>The National Health Service has a network of clinicians and infectious diseases units that work in a collaborative manner to manage patients with infectious diseases. In rare and complex infections, treatment is likely to include the use of isolation facilities with appropriate air handling and air filtration systems (for the protection of staff and public as per the Health and Safety Executive Advisory Committee on Dangerous Pathogens guidelines). The use of beds is managed through the network and escalated as necessary based on the needs of the presenting patient. This network of units will continue to work together with NHS England to manage the current threat of Ebola as they would with any new or emerging infectious disease.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/10/2014 16:18:04 answering member 3918 label Biography information for Jane Ellison
tabling member	308 label Biography information for Mr Jim Cunningham

93573

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund: Liverpool
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what proportion of the cancer drugs fund has been spent in Liverpool since its inception.
tabling member constituency	Liverpool, Walton
tabling member printed	Steve Rotheram
uin	210689
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>Prior to April 2013, information on the Cancer Drugs Fund was administered through clinical panels based in each strategic health authority (SHA) and data on spend through the Fund in each city was not collected. Information on spend by the North West SHA and in England in 2010-11, 2011-12 and 2012-13 is shown in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Amount Spent (£000)</p><p>2010-11</p></td><td><p>Amount Spent (£000)<br> 2011-12</p></td><td><p>Amount Spent (£000)<br> 2012-13</p></td></tr><tr><td><p>North West SHA</p></td><td><p>7,400</p></td><td><p>10,015</p></td><td><p>29,272</p></td></tr><tr><td><p>England</p></td><td><p>38,254</p></td><td><p>108,327</p></td><td><p>175,334</p></td></tr></tbody></table><p> </p><p><em>Source</em>: Information provided to the Department by SHAs</p><p> </p><p> </p><p> </p><p>NHS England has had oversight of the Fund since April 2013 and does not collect information at city level. In 2013-14, £63,368,429 was spent through the Fund in the North of England region and total national expenditure in England, net of any central rebates, was £230,539,005. Figures for 2014-15 are not currently available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:20:31 answering member 4020 label Biography information for George Freeman
tabling member	4035 label Biography information for Steve Rotheram